Plain-English translation of NCT07228117 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new insulin pump system called the MiniMed NMX8-AID, which works together with a glucose sensor to help manage diabetes automatically. Researchers want to make sure the pump is safe and works well for people with type 1 diabetes (ages 7–85) and type 2 diabetes (ages 18–85). You would wear the sensor first for a few weeks, then use the new pump for about 3 months while researchers track how it affects your blood sugar and overall health.
Current insulin pumps require patients to decide when and how much insulin to take for meals. This new system may reduce some of that burden by automatically adjusting insulin delivery, but the company needs to confirm it's safe before wider use.
You likely qualify if…
You likely don't qualify if…
First, you'll wear a glucose sensor for up to 40 days while continuing your current diabetes treatment and keeping a log of meals and exercise. Then you'll be randomly assigned to one of three groups: one that uses the new pump without giving boluses (insulin doses) for meals, one that gives boluses for all meals, or one where you choose whether to bolus. You'll use the assigned approach for about 90 days, keep logging your meals and exercise, and upload your pump data regularly. If you like the pump at the end, you may be able to continue using it in a follow-up program.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States